USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program

Funded by USAID and implemented by a team led by MSH, the purpose of the five-year MTaPS program (2018–2023) is to provide pharmaceutical system strengthening (PSS) assistance for sustained improvements in health system performance and to advance USAID’s goals of preventing child and maternal deaths, controlling the HIV/AIDS epidemic, combating infectious disease threats, and expanding essential health coverage. The goal of the MTaPS program is to help low and middle-income countries (LMICs) strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medicines, vaccines, and other health technologies and pharmaceutical services. MTaPS’ objectives: 1. Strengthen pharmaceutical-sector governance 2. Increase institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products 3. Advance availability and use of pharmaceutical information for decision-making and the global learning agenda 4. Optimize pharmaceutical-sector financing, including resource allocation and use 5. Improve pharmaceutical services, including product availability and patient-centered care, to achieve desired health outcomes MTaPS’ Approach The program’s theory of change is based on USAID’s vision for PSS, which posits six functions of health systems that must be strengthened to achieve sustained and equitable access to essential, high-quality services: human resources, health finance, health governance, health information, medical products/vaccines/technologies, and service delivery. Learn more at https://www.mtapsprogram.org/